Background: THC can be measured in blood up to a month after last intake in heavy cannabis users. The cognitive deficits during abstinence have been hypothesized to be at least in part due to residual THC in brain. To which extent THC accumulation will occur after occasional cannabis use has gained limited attention. We aimed to predict THC-levels between smoking sessions in non-daily as well as daily cannabis users and to compare these predictions with published THC levels. Methods: Predictions were based on pharmacokinetic principles on drug accumulation after repeated dosing, applied to different cannabis smoking patterns, using data from a three-compartment model for THC pharmacokinetics and results on the terminal elimination half-life...
BACKGROUND: Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) time courses in serum and physiologi...
A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...
Introduction: THC-COOH has been proposed as a criterion to help to distinguish between occasional fr...
AIMS—To quantify blood Δ9-tetrahydrocannabinol (THC) concentrations in chronic cannabis users over s...
Cannabis smoking increases motor vehicle accident risk. Empirically defined cannabinoid detection wi...
Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...
THC (THCCOOH) have been reported in blood from frequent cannabis smokers for an extended time during...
Cannabis use produces dose-related impairments in cognitive and behavioral functions that may induce...
International audienceBackground: The endogenous cannabinoid system (ECS), including the endocannabi...
Previous investigators have found no clear relationship between specific blood concentrations of ∆-t...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
International audiencePurpose. A randomized cross-over, double blind placebo controlled study of smo...
Some forensic and clinical circumstances require knowledge of the frequency of drug use. Care of the...
BACKGROUND: Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) time courses in serum and physiologi...
A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...
Introduction: THC-COOH has been proposed as a criterion to help to distinguish between occasional fr...
AIMS—To quantify blood Δ9-tetrahydrocannabinol (THC) concentrations in chronic cannabis users over s...
Cannabis smoking increases motor vehicle accident risk. Empirically defined cannabinoid detection wi...
Cannabinoid pharmacokinetics in occasional users is well studied, but the interpretation of data fro...
THC (THCCOOH) have been reported in blood from frequent cannabis smokers for an extended time during...
Cannabis use produces dose-related impairments in cognitive and behavioral functions that may induce...
International audienceBackground: The endogenous cannabinoid system (ECS), including the endocannabi...
Previous investigators have found no clear relationship between specific blood concentrations of ∆-t...
"Light cannabis" is a product legally sold in Europe with Δ9-tetrahydrocannabinol (THC) concentratio...
International audiencePurpose. A randomized cross-over, double blind placebo controlled study of smo...
Some forensic and clinical circumstances require knowledge of the frequency of drug use. Care of the...
BACKGROUND: Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) time courses in serum and physiologi...
A cross-over controlled administration study of smoked cannabis was carried out on occasional and he...
Introduction: THC-COOH has been proposed as a criterion to help to distinguish between occasional fr...